Invention Grant
US07863333B2 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
有权
N-烷基化二氨基丙烷衍生物作为趋化因子受体活性的调节剂
- Patent Title: N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
- Patent Title (中): N-烷基化二氨基丙烷衍生物作为趋化因子受体活性的调节剂
-
Application No.: US11946133Application Date: 2007-11-28
-
Publication No.: US07863333B2Publication Date: 2011-01-04
- Inventor: Percy H. Carter
- Applicant: Percy H. Carter
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Laurelee A. Duncan; Terence J. Bogie
- Main IPC: A61K31/16
- IPC: A61K31/16 ; C07C233/00
Abstract:
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
Public/Granted literature
- US20080113976A1 N-ALKYLATED DIAMINOPROPANE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Public/Granted day:2008-05-15
Information query
